|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 171 JPY | -0.58% |
|
-1.72% | -30.77% |
SymBio Pharmaceuticals Limited reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was JPY 3,178.67 million compared to JPY 4,873.7 million a year ago. Net loss was JPY 79.85 million compared to net income of JPY 1,108.09 million a year ago.
Basic loss per share from continuing operations was JPY 2.02 compared to basic earnings per share from continuing operations of JPY 28.71 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -30.77% | 51.17M | |
| +31.52% | 690B | |
| +21.96% | 546B | |
| -5.21% | 358B | |
| +17.02% | 323B | |
| +5.01% | 287B | |
| +13.68% | 235B | |
| +3.81% | 199B | |
| -10.63% | 195B | |
| +3.98% | 161B |
SYMBIO PHARMACEUTICALS LIMITED 